Endoscopic reflux treatment in Istanbul: which option is worth discussing?

The short version

• Establish what is causing the symptoms before selecting a procedure.

• Endoscopic reflux treatments are not interchangeable; evidence depends on the technique and patient group.

• Ask about medicines, surgical alternatives, complications and follow-up—not only whether a treatment is “incisionless”.

Still having heartburn: does that mean you need a procedure?

Not necessarily. A consultation should explore your symptoms, medicines and previous investigations. Persistent symptoms may need testing rather than an immediate treatment booking.

Endoscopy can look for damage or another explanation. Reflux monitoring can help establish whether reflux is present and how it relates to symptoms. Your clinician decides which investigations are useful; not everyone needs every test. NIDDK: diagnosis

Difficulty or pain when swallowing, unexplained weight loss, bleeding, persistent vomiting or unexplained iron-deficiency anaemia warrant prompt medical assessment. New or severe chest pain should not be assumed to be reflux: seek urgent local care. ASGE guideline

Sources: [1][3]

What do the different names mean?

Gerd-X / GERDx: an endoscopic plication approach that creates tissue folds. A single-centre, sham-controlled trial reported improvements in selected people with PPI-dependent GERD. That does not prove it is the best choice for every patient or establish a lifetime result. Original trial

ARMS: antireflux mucosectomy, involving removal of selected lining tissue. ESGE's 2020 guideline advised against routine clinical use because of insufficient evidence and potential complications. It is important to distinguish that dated recommendation from a claim about current Turkish regulation. ESGE guideline

ARMA: antireflux mucosal ablation. A multicentre sham-controlled trial published in 2026 studied PPI-responsive GERD. It found no significant advantage in the main quality-of-life outcome at 12 months; pain and swallowing difficulty were more frequent after ARMA. Its authors did not support routine implementation. These findings concern that study population, not every possible reflux presentation. 2026 original trial

ARBL: a label used for antireflux band-ligation approaches. Ask the clinician to specify the exact technique, the evidence applicable to you and its current availability. Do not assume evidence for another endoscopic method applies to band ligation. A recent comparative study is listed in the references, but its results are not used here to promise benefit. Original comparative study

Stretta: a radiofrequency-based approach. ASGE's 2025 guideline describes a limited role in confirmed GERD with a small hiatal hernia when other endoscopic or surgical fundoplication options are unavailable or impractical; the supporting evidence is very low certainty. This is not a first-choice recommendation for everyone. ASGE guideline

Sources: [5][4][6][7][3]

What alternatives should you compare?

Lifestyle measures and acid-suppressing medicines remain important options. PPIs can be effective; wanting to avoid a daily tablet is a reason for a discussion, not proof that an intervention is safer. Do not change prescribed medication solely on the basis of this article. NIDDK: treatment

Depending on confirmed disease and anatomy, a specialist may discuss surgery or another endoscopic approach. ASGE recommends assessment for TIF in selected patients, and multidisciplinary consideration of combined hernia repair and TIF for certain larger hernias. TIF is not another name for Gerd-X, ARMA or Stretta. Mentioning an alternative does not confirm its availability through Unimed. ASGE guideline

Sources: [2][3]

Which risks need a plain-language explanation?

“Through the mouth” does not mean risk-free. Ask about sedation, bleeding, perforation, pain, swallowing difficulty, narrowing, persistent symptoms and the possibility of further treatment. The relevant risks differ by method; a single generic consent description is not enough.

For example, swallowing difficulty was more common after ARMA than sham endoscopy in the 2026 trial. Ask how such a problem would be recognised, who would treat it and what happens if you have already returned home. ARMA trial Gerd-X trial

Sources: [6][5]

What should follow-up look like?

Before consenting, request an individual written plan covering diet, medication, activity, warning symptoms and review appointments. Ask whether symptom review alone is enough or whether repeat testing will be needed.

There is no single recovery schedule for this whole group of procedures. Confirm fitness to travel with the treating team, not from a package itinerary. Ask who is available out of hours, how urgent complications are handled and what information your local clinician will receive.

A useful question is: “If the symptoms persist, what is the next step—and who coordinates it?”

How can you plan an assessment in Istanbul, Turkey?

Unimed's supplied doctor profile lists endoscopic reflux applications for Prof. Dr. Barış Yılmaz. The exact method, availability and suitability must be confirmed by the responsible clinician. This article does not imply the doctor has reviewed it.

Prepare a symptom summary, medication list and any existing endoscopy or reflux-test reports. Ask the coordination team how to transfer records confidentially; avoid posting medical documents publicly.

Confirm the facility, responsible clinician, itemised costs and follow-up arrangements before booking travel. You can contact Unimed on WhatsApp: +90 545 234 63 74 to discuss assessment arrangements. This is not an emergency service.